61 assets in Morbid Obesity

Therapeutic assets addressing Morbid Obesity, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lidocaine Morbid Obesity	Instituto Mexicano del Seguro Social	P4	BBB (75)
Propofol Morbid Obesity	G.Gennimatas General Hospital	P4	BBB (73)
Ramifentanyl Morbid Obesity	Hospital dos Lusíadas	P4	BBB (73)
Semaglutide Morbid Obesity	Zuyderland Medisch Centrum	P4	BBB (72)
Dexmedetomidine Morbid Obesity	Cairo University	P4	BB (70)
Liraglutide Morbid Obesity	University of Sao Paulo General Hospital	P4	BB (70)
Marcaine Morbid Obesity	Amany Ahmed Eissa	P4	BB (70)
Nepenthe Morbid Obesity	Kirsehir Ahi Evran Universitesi	P4	BB (69)
Fentanyl Morbid Obesity	Cairo University	P4	BB (68)
Rocuronium Ion Morbid Obesity	Hospital dos Lusíadas	P4	BB (68)
Gabapentin Morbid Obesity	Tanta University	P4	BB (67)
Ibuprofen Morbid Obesity	Cairo University	P4	BB (67)
Ondansetron Morbid Obesity	Tanta University	P4	BB (65)
Midazolam Morbid Obesity	Amany Ahmed Eissa	P4	BB (64)
Dilaudid Morbid Obesity	University of California, Davis	P4	B (62)
Esomeprazole Morbid Obesity	Hospital dos Lusíadas	P4	B (62)
Hycet Morbid Obesity	University of California, Davis	P4	B (62)
Hyoscine Morbid Obesity	University of California, Davis	P4	B (62)
Indocyanine Green Morbid Obesity	University Health Network, Toronto	P4	B (62)
Naltrexone Morbid Obesity	Laval University	P4	B (62)
Oxycodone Morbid Obesity	University of California, Davis	P4	B (62)
Remimazolam Morbid Obesity	Seoul National University Bundang Hospital	P4	B (62)
Tranexamic Acid Morbid Obesity	Patel Hospital, Pakistan	P4	B (62)
Supemtek® Morbid Obesity	Assistance Publique - Hôpitaux de Paris	P3	B (60)
Vaxigriptetra® Morbid Obesity	Assistance Publique - Hôpitaux de Paris	P3	B (60)
Baclofen Morbid Obesity	Tanta University	P2/3	B (58)
Cyclobenzaprine Morbid Obesity	University of California, Davis	P4	B (58)
Lorazepam Morbid Obesity	University of California, Davis	P4	B (58)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone Morbid Obesity	Cairo University	P3	B (57)
Human Faecal Matter Morbid Obesity	Wiebke Kristin Fenske	P2	B (57)
Tirzepatide Morbid Obesity	Azienda Sanitaria Locale Napoli 2 Nord	P2/3	CCC (55)
Enoxaparin Morbid Obesity	Alexandria University	P1/2	CCC (53)
Rivaroxaban Morbid Obesity	Alexandria University	P1	CC (44)
Edoxaban Morbid Obesity	Institut universitaire de cardiologie et de pneumologie de Québec, University Laval	P1	CC (43)
Cannabivarol, .Delta.9-Tetrahydro- Morbid Obesity	Medical Life Care Planners, LLC	Early P1	CC (41)
Misoprostol Morbid Obesity	University of Maryland, Baltimore	Early P1	C (38)
Bemiparin Morbid Obesity	Hawler Medical University	N/A	D (30)
Cholestyramine Morbid Obesity	Centre Hospitalier Universitaire de Nice	N/A	D (30)
Dexasone Morbid Obesity	YingHsuanTai	N/A	D (30)

Showing 1 to 50 of 61 assets

PreviousPage 1 of 2Next